The President's Cancer Panel issued recommendations aimed at promoting value, affordability, and innovation in cancer drugs. The recommendations include increasing NIH funding, encouraging the development of generic and biosimilar drugs, and instituting value-based pricing policies to encourage the development of cost-effective drugs.
https://ift.tt/2rc3Dq5
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου